Drs. Oz & Roizen's Tip of the Day: Arthritis sufferers, don't give up

King Features SydicateJuly 17, 2013 

When the French Impressionist Pierre-Auguste Renoir developed rheumatoid arthritis in the 1890s, there was nothing but mineral baths, aspirin and red wine to ease his pain and prevent his hands from becoming deformed.

About a hundred years later, in the 1980s, when heart surgeon Christian Barnard (he did the first heart transplant) was forced to retire because of RA's crippling effects, treatment options were still limited. Disease modifying anti-rheumatic drugs, or DMRDs, such as methotrexate, were just coming into widespread and effective use.

In the past decade, 10 approved biologic medications have become game-changers. They promise great benefits (with some risks, such as increased infections and some cancers) when other treatments don't work. This has made doctors and patients more optimistic about slowing joint damage, preserving mobility -and even achieving remission.

So why do more than half of RA patients stop taking their medication or grudgingly switch therapies within two years? Almost 40 percent report that their meds aren't working the way they want them to, and 20 percent say it's because they are worried about side effects.

But having to try a new combination of medications is not failure; with RA that's the process you have to go through to discover what works best for you. So let your doctor know your concerns and expectations and explain how your meds affect you. Chances are very good you will be rewarded with a new treatment plan that provides big improvements in your quality of life.

Don't stop treatment; find out what works for you.

Mehmet Oz, M.D., is host of "The Dr. Oz Show," and Mike Roizen, M.D., is chief medical officer at the Cleveland Clinic Wellness Institute. To live your healthiest, visit sharecare.com. Distributed by King Features Syndicate, Inc.

Idaho Statesman is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

Commenting FAQs | Terms of Service